Oncomatryx, a start-up member of the Basque Health Cluster, has started the year by raising 15 million euros to carry out phase I clinical trials. In addition to its existing shareholders, including...
[vc_row][vc_column][vc_column_text] The BIKAINTEK 2022 call will be open until the 29th of April. In the BOPV published on the 2nd of March, we can find the terms and conditions of this aid...
[vc_row][vc_column][vc_column_text].SAFE-N-MEDTECH – Safety testing in the life cycle of nanotechnology-enabled medical technologies for health – is an international project focused on enabling...
MODIFICATION TO THE STRATEGIC ACTION IN HEALTH 2021-2023 In the middle of last month, the government presented the 15 calls for Strategic Action in Health (AES) that will be opened throughout...
Our member e-Process Med has obtained funding from the Consejería de Salud y Familias of Andalusia. The project, entitled “D&SAI: Artificial Intelligence-based COVID screening and...
On 15 February, the Basque Health Cluster, together with members Innoprot, Bexen medical and Biolan Health, explained the situation of the sector and the changes brought about by the pandemic. In the...
[vc_row][vc_column][vc_column_text].Basque Health Cluster organizes an intensive course on the new Regulations for medical devices (MD) and in vitro diagnostic medical devices (IVD) under the new...
As it did last year, this month the Basque Government’s Department of Economic Development, Sustainability and the Environment published the aid programmes for Basque SMEs for 2022. The 2021 SME...
“We need faster, more reliable and cost-effective diagnostic systems and data management tools that accelerate health decisions and facilitate patient treatment.”.The breakthroughs of the...
In these first months of the year, the State Government has begun to date the aid proposed for this year. .NEW CALENDAR OF CALLS FOR PROPOSALS UNDER THE RECOVERY, TRANSFORMATION AND...
Many European SMEs in the health sector will not be able to certify their equipment in time and will be immediately banned from marketing their products. As a result, they will face serious survival...
After more than 35 years carrying out studies on the efficacy and safety of products using in vitro systems and models, the GAIKER technology centre is now a benchmark in this field for the...
